$NUMD
Nu-Med Plus, Inc.

2022 Q4 Form 10-Q Financial Statement

#000154812322000202 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.390K $58.02K $115.7K
YoY Change -94.17% -49.86% -74.1%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $40.00 $2.650K
YoY Change -100.0% -98.49% -12.83%
% of Gross Profit
Operating Expenses $6.390K $58.05K $118.4K
YoY Change -94.31% -50.96% -73.68%
Operating Profit -$58.05K -$118.4K
YoY Change -50.96%
Interest Expense -$1.000K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $42.61K -$58.05K -$118.4K
YoY Change -137.93% -50.96% -73.92%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $42.61K -$58.05K -$118.4K
YoY Change -137.93% -50.96% -73.92%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$1.492K
COMMON SHARES
Basic Shares Outstanding 81.35M shares 79.35M shares 79.35M shares
Diluted Shares Outstanding 79.74M shares 79.35M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.20K $630.00 $31.84K
YoY Change 526.71% -98.02% 1.08%
Cash & Equivalents $73.20K $628.00 $31.84K
Short-Term Investments
Other Short-Term Assets $6.350K $2.540K $2.830K
YoY Change -10.25% -99.52%
Inventory
Prepaid Expenses $6.350K $2.540K
Receivables
Other Receivables
Total Short-Term Assets $79.55K $3.168K $34.67K
YoY Change 581.33% -90.86% -94.45%
LONG-TERM ASSETS
Property, Plant & Equipment $4.916K
YoY Change -80.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $16.57K
YoY Change -100.0% -34.38%
TOTAL ASSETS
Total Short-Term Assets $79.55K $3.168K $34.67K
Total Long-Term Assets $0.00 $16.57K
Total Assets $79.55K $3.168K $51.24K
YoY Change 258.91% -93.82% -92.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.192K $59.37K $38.54K
YoY Change -74.08% 54.04% -23.09%
Accrued Expenses $1.000K $144.6K $82.71K
YoY Change -98.92% 74.77% -40.19%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $142.6K $273.3K $121.3K
YoY Change -7.73% 125.4% -71.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.6K $273.3K $121.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $142.6K $273.3K $121.3K
YoY Change -7.73% 125.4% -71.66%
SHAREHOLDERS EQUITY
Retained Earnings -$9.699M -$9.742M
YoY Change 1.36%
Common Stock $81.35K $81.35K
YoY Change 2.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$63.03K -$270.1K -$70.02K
YoY Change
Total Liabilities & Shareholders Equity $79.55K $3.168K $51.24K
YoY Change 258.91% -93.82% -92.11%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $42.61K -$58.05K -$118.4K
YoY Change -137.93% -50.96% -73.92%
Depreciation, Depletion And Amortization $0.00 $40.00 $2.650K
YoY Change -100.0% -98.49% -12.83%
Cash From Operating Activities -$24.43K $630.00 -$40.99K
YoY Change 21.18% -101.54% -59.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0K 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -24.43K 630.0 -40.99K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 100.0K 0.000 0.000
Net Change In Cash 75.57K 630.0 -40.99K
YoY Change -474.85% -101.54% -261.38%
FREE CASH FLOW
Cash From Operating Activities -$24.43K $630.00 -$40.99K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Other Income
OtherIncome
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54808
dei Entity Registrant Name
EntityRegistrantName
NU-MED PLUS, INC.
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3672530
dei Entity Address Address Line1
EntityAddressAddressLine1
455 East 500 South, Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
746-3570
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81348469 shares
CY2022Q3 us-gaap Cash
Cash
628 usd
CY2021Q4 us-gaap Cash
Cash
11675 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2540 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
3168 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11675 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8222 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266 usd
CY2022Q3 us-gaap Assets
Assets
3168 usd
CY2021Q4 us-gaap Assets
Assets
22163 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
59366 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27744 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
69378 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
26000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
144555 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92555 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8222 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
273299 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
154521 usd
CY2022Q3 us-gaap Liabilities
Liabilities
273299 usd
CY2021Q4 us-gaap Liabilities
Liabilities
154521 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81348469 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81348469 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79348469 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79348469 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
81349 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
79349 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9390587 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9357587 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9742067 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9569294 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-270131 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-132358 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3168 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22163 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5702 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6947 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19900 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20717 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
35000 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
65486 usd
us-gaap Salaries And Wages
SalariesAndWages
59000 usd
us-gaap Salaries And Wages
SalariesAndWages
202458 usd
CY2022Q3 numd Operating Lease Rent Expense
OperatingLeaseRentExpense
1559 usd
CY2021Q3 numd Operating Lease Rent Expense
OperatingLeaseRentExpense
6285 usd
numd Operating Lease Rent Expense
OperatingLeaseRentExpense
8971 usd
numd Operating Lease Rent Expense
OperatingLeaseRentExpense
18814 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
15755 usd
CY2021Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
36999 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
85635 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
478400 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34 usd
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2649 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2267 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6715 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
58050 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
118366 usd
us-gaap Operating Expenses
OperatingExpenses
175773 usd
us-gaap Operating Expenses
OperatingExpenses
727104 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58050 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-118366 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-175773 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-727104 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
9384 usd
us-gaap Other Income
OtherIncome
3000 usd
us-gaap Other Income
OtherIncome
9384 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-58050 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-118366 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-172773 usd
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-717720 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-58050 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-118366 usd
us-gaap Net Income Loss
NetIncomeLoss
-172773 usd
us-gaap Net Income Loss
NetIncomeLoss
-717720 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79739773 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79348469 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79480337 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79324733 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-132358 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-56653 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-189011 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-58070 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-247081 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-58050 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-270131 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
467703 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-356748 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
190955 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-242606 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1651 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-118366 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-70017 usd
us-gaap Net Income Loss
NetIncomeLoss
-172773 usd
us-gaap Net Income Loss
NetIncomeLoss
-717720 usd
us-gaap Depreciation
Depreciation
2266 usd
us-gaap Depreciation
Depreciation
6715 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3000 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
9384 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
8222 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7981 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
35000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
150000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2540 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-346184 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8222 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7981 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31622 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7504 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
43378 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
52000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
45043 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14047 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-186666 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11047 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-156666 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11675 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188506 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
628 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31840 usd
us-gaap Stock Issued1
StockIssued1
724314 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">c. Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</p>
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
500 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">h. Concentrations and Credit Risk <b><i>- </i></b>The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81348469 shares
numd Planned Expenditures
PlannedExpenditures
1200000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83893 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90368 usd
CY2022Q3 numd Accumulated Depreciation
AccumulatedDepreciation
83893 usd
CY2021Q4 numd Accumulated Depreciation
AccumulatedDepreciation
88102 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2266 usd
us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
2266 usd
us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
6715 usd
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
3000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 usd
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81348469 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79348469 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79348469 shares
us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
2000000 shares
CY2017Q1 numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
950 usd
CY2017Q4 numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
978 usd
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1008 usd
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1038 usd
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1058 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
8222 usd
CY2022Q3 numd Discount Rate Percentage
DiscountRatePercentage
0.08 pure
CY2021Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
500000 shares
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
565500 usd
CY2020Q1 us-gaap Derivative Term Of Contract
DerivativeTermOfContract
P1Y
CY2020Q1 us-gaap Other Expenses
OtherExpenses
3500 usd
numd Agreements Description
AgreementsDescription
In addition, Hanover received 750,000 shares of restricted common stock, earned in quarterly tranches of 187,500 shares, deemed earned and issuable after services are provided for each quarter. As of September 30, 2022 all of the shares to which the Company is obligated under this agreement have been issued and the total value of $375,000 has been fully amortized.
CY2022Q3 numd Agreements Description
AgreementsDescription
The Agreement provides a rate of $120,000 per for the initial year, $135,000 for the second year and $150,000 for the final year, which fees shall be accrued until the Company receives adequate funding with which to pay such fees.
CY2022Q3 numd Additional Shares Restricted Common Stock
AdditionalSharesRestrictedCommonStock
2000000 shares
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022Q3 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
CY2021Q3 us-gaap Other Income
OtherIncome
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79324733 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79348469 shares
CY2021Q1 numd Common Stock Issued Under Subscription Agreements
CommonStockIssuedUnderSubscriptionAgreements
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
usd
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001543637

Files In Submission

Name View Source Status
0001548123-22-000202-index-headers.html Edgar Link pending
0001548123-22-000202-index.html Edgar Link pending
0001548123-22-000202.txt Edgar Link pending
0001548123-22-000202-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
numd-20220930.htm.htm Edgar Link pending
numd-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
numd-20220930_def.xml Edgar Link unprocessable
numd-20220930_cal.xml Edgar Link unprocessable
numd-20220930_lab.xml Edgar Link unprocessable
numd-20220930_pre.xml Edgar Link unprocessable
numd-20220930.htm_htm.xml Edgar Link completed